Reverse Convertible Bond 11,75 % Impfstoff Aktienanleihe

Bid43.60%
Mar 29, 2023 17:59:59.907 UTC
Ask45.10%
Mar 29, 2023 17:59:59.907 UTC
chg. 1D+0.080 (+0.18%)
Mar 29, 2023 17:59:59.907 UTC
Underlying price (delayed)-
--
Barrier- StrikeEUR 100.00 Max. yield p.a.- Interest rate p.a.11.75%

Name
Reverse Convertible Bond on Worst of Basket
ISIN / WKN
AT0000A2RZF6 / RC035L
Underlying
Max. yield remaining term (%)
>100%
Max. yield p.a.
-
Interest rate total term
-
Fixed interest rate annually
11.75%
Underlying price (delayed)
- --
-
Starting value
EUR 100.00
Strike
EUR 100.00
Barrier
-
Distance to strike
-159.80%
Distance to barrier
-
Barrier reached
yes (Barrier: EUR 55.00)
No. of shares
-
Tradeable unit/nominal value
EUR 1,000
Paid interest rate
11.75% (EUR 117.50) on Aug 04, 2022
About the term

Initial valuation date
Aug 03, 2021
Issue date
Aug 04, 2021
Final valuation date
Aug 01, 2023
Maturity date
Aug 04, 2023

Product classification
Investment Product without Capital Protection
Security type (Eusipa No.)
Reverse Convertible Bond (1230)
Reverse Convertible Bond Type
Barrier Reverse Convertible Bonds
Underlying
Country / region of underlying
-
Suited market expectation
sideways, bullish
Observation barrier
Closing Price
Issue price
100.00%
Spread homogenised
1.50
Spread (in %)
3.44%
Product currency
EUR
Underlying currency
EUR
Settlement method
Cash settlement / Physical delivery
Taxation
Capital Gains Tax / Foreign Capital Gains Tax
Public offer possible in
Austria, Germany, Italy, Hungary, Poland, Czech Republic, Slovakia, Bulgaria, Croatia, Romania, Slovenia
Listing
Vienna, Frankfurt, Stuttgart
Description

The 11.75% Vaccination Reverse Convertible Bond is redeemed at 100% nominal value at the maturity date (Aug. 2023), provided that, during the observation period, the closing price of each of the two underlying shares (BioNTech SE, Moderna Inc.) always quoted above the barrier of 55% of the strike (daily observation). The interest amount of 11.75% is paid out annually, regardless of the performance of the underlying shares.

If the barrier of at least one of the two shares is violated and at least one of the underlying shares is quoted below its strike price, only the share with the worst performance is physically delivered. If both underlying shares quote at or above their strike at the final valuation date, the product is redeemed at 100% nominal value despite a barrier event.

The barrier has been touched by Moderna Inc on January 13, 2022.

TRADING HOURS
Products on Austrian underlyings9:15 am - 5:30 pm

Products on underlyings of CEE, Eastern Europe and Turkey

 

 - Turkey, Czech Republic9:00 am - 4:00 pm
 - Russia, Croatia, Ukraine, Kazakhstan9:15 am - 4:30 pm
 - Poland, Hungary, Romania, CEE and Eastern Europe9:15 am - 4:50 pm
  
Products on other international underlyings and commodities
(incl. Germany and Switzerland)
9:00 am - 8:00 pm
INFORMATION

Monday - Friday
8:00 am to 5:30 pm

T: +431717075454
E: info(at)raiffeisencertificates.com